OBJECTIVE: The aim of our study was to investigate the association between REV-ERBalpha gene (NR1D1) single nucleotide polymorphisms (SNPs) and bipolar disorder (BP) in a case-control sample of Sardinian ancestry and evaluate its effect on age at onset (AAO) of BP. METHODS: We genotyped SNPs rs12941497 (SNP1) and rs939347 (SNP2), located, respectively, in the first intron and in the 5'UTR region of the gene, in a sample comprised of 300 bipolar patients and 300 healthy controls of Sardinian ancestry. We also studied AAO by means of admixture analysis, obtaining a cutoff point of age 22 and then carrying out association analysis between the two AAO groups. RESULTS: In the case-control comparison, single marker analysis showed no association for any of the SNPs tested. Haplotype analysis showed a nominally significant association for two haplotypes of SNPs 1-2. Comparing the early- and later-onset groups, nominal association was found for SNP1. Haplotype analysis showed that one haplotype was nominally associated with the later-onset group. CONCLUSIONS: Our results, indicating a nominal association of the REV-ERBalpha gene with BP, suggest a possible role of REV-ERBalpha in the pathogenesis of BP. Further investigation of larger independent samples and different populations is warranted.
OBJECTIVE: The aim of our study was to investigate the association between REV-ERBalpha gene (NR1D1) single nucleotide polymorphisms (SNPs) and bipolar disorder (BP) in a case-control sample of Sardinian ancestry and evaluate its effect on age at onset (AAO) of BP. METHODS: We genotyped SNPs rs12941497 (SNP1) and rs939347 (SNP2), located, respectively, in the first intron and in the 5'UTR region of the gene, in a sample comprised of 300 bipolarpatients and 300 healthy controls of Sardinian ancestry. We also studied AAO by means of admixture analysis, obtaining a cutoff point of age 22 and then carrying out association analysis between the two AAO groups. RESULTS: In the case-control comparison, single marker analysis showed no association for any of the SNPs tested. Haplotype analysis showed a nominally significant association for two haplotypes of SNPs 1-2. Comparing the early- and later-onset groups, nominal association was found for SNP1. Haplotype analysis showed that one haplotype was nominally associated with the later-onset group. CONCLUSIONS: Our results, indicating a nominal association of the REV-ERBalpha gene with BP, suggest a possible role of REV-ERBalpha in the pathogenesis of BP. Further investigation of larger independent samples and different populations is warranted.
Authors: Virginia Soria; Erika Martínez-Amorós; Geòrgia Escaramís; Joaquín Valero; Rosario Pérez-Egea; Cecilia García; Alfonso Gutiérrez-Zotes; Dolors Puigdemont; Mònica Bayés; José M Crespo; Lourdes Martorell; Elisabet Vilella; Antonio Labad; Julio Vallejo; Víctor Pérez; José M Menchón; Xavier Estivill; Mònica Gratacòs; Mikel Urretavizcaya Journal: Neuropsychopharmacology Date: 2010-01-13 Impact factor: 7.853
Authors: Robert Keers; Inti Pedroso; Gerome Breen; Kathy J Aitchison; Patrick M Nolan; Sven Cichon; Markus M Nöthen; Marcella Rietschel; Leonard C Schalkwyk; Cathy Fernandes Journal: PLoS One Date: 2012-06-15 Impact factor: 3.240
Authors: Ian B Hickie; Sharon L Naismith; Rébecca Robillard; Elizabeth M Scott; Daniel F Hermens Journal: BMC Med Date: 2013-03-22 Impact factor: 8.775